www.fdanews.com/articles/127196-soligenix-granted-us-patent-for-treatment-of-irritable-bowel-syndrome
Soligenix Granted US Patent for Treatment of Irritable Bowel Syndrome
May 19, 2010
Soligenix, a late-stage biopharmaceutical company, announced Wednesday that the United States Patent Office has issued a patent (US 7,704,985) titled “Treatment of Irritable Bowel Syndrome and Related Bowel Diseases.”
Forbes
Forbes